Immune responses to pertussis vaccines and disease

Journal of Infectious Diseases

Volumn 209, Issue SUPPL. 1, 2014, Pages

  Edwards, Kathryn M ^a   Berbers, Guy A M ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

acellular pertussis vaccines; DTaP; DTwP; pertussis vaccines; whole cell pertussis vaccines

Indexed keywords

ACELLULAR PERTUSSIS VACCINES; DTAP; DTWP; PERTUSSIS VACCINES; WHOLE CELL PERTUSSIS VACCINES;

ANTIBODIES, BACTERIAL; B-LYMPHOCYTES; HUMANS; IMMUNOLOGIC MEMORY; PERTUSSIS VACCINE; T-LYMPHOCYTE SUBSETS; VACCINES, ACELLULAR; VACCINES, INACTIVATED; WHOOPING COUGH;

EID: 84898936905     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit560     Document Type: Article

References (38)

1. Edwards KM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: Overview and serologic response. Pediatrics 1995; 96:548-57
2. Decker MD, Edwards KM, Steinhoff MC, et al. Comparison of 13 acellular pertussis vaccines: Adverse reactions. Pediatrics 1995; 96:557-66
3. Meade BD, Deforest A, Edwards KM, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics 1995; 96:570-5
4. Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WAOffit PA, eds. Vaccines. 6th ed. Philadelphia: Elsevier, 2013:447-92
5. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996; 334:349-55. (Pubitemid 26049587)
6. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progretto PertosseWorking Group. N Engl J Med 1996; 334:341-8. (Pubitemid 26053148)
7. Lambert L. Pertussis vaccine trials in the 1990s. J Infect Dis 2014: S12-7
8. Giuliano M, Mastrantonio P, Giammanco A, Piscitelli A, Salmaso S, Wassilak SG. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. J Pediatr 1998; 132:983-8
9. Pichichero ME, Deloria MA, Rennels MB, et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one wholecell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics 1997; 100:772-88. (Pubitemid 27463312)
10. Pichichero ME, Edwards KM, Anderson EL, et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics 2000; 105:e11
11. Cassone A, Ausiello CM, Urbani F, et al. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch Pediatr Adolesc Med 1997; 151:283-9. (Pubitemid 27133213)
12. Ausiello CM, Urbani F, la Sala A, Lande R, Cassone A. Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines. Infect Immun 1997; 65:2168-74. (Pubitemid 27237293)
13. Ross PJ, Sutton CE, Higgins S, et al. Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: Towards the rational design of an improved acellular pertussis vaccine. PLoS Pathogens 2013; 9:e1003264
14. Schure RM, Hendrikx LH, de Rond LG, et al. T-cell responses before and after the fifth consecutive acellular pertussis vaccination in 4-yearold Dutch children. Clin Vaccine Immunol 2012; 19:1879-86
15. Ryan M, Murphy G, Gothefors L, Nilsson L, Storsaeter J, Mills KH. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis 1997; 175:1246-50. (Pubitemid 27176522)
16. Ward JI, Cherry JD, Chang SJ, et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005; 353:1555-63. (Pubitemid 41434634)
17. Le T, Cherry JD, Chang SJ, et al. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: The APERT Study. J Infect Dis 2004; 190:535-44
18. McIntyre PB, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-Tetanus-Acellular pertussis vaccine. Vaccine 2004; 23:380-5. (Pubitemid 39467727)
19. Kirkland KB, Talbot EA, Decker MD, Edwards KM. Kinetics of pertussis immune responses to tetanus-diphtheria-Acellular pertussis vaccine in health care personnel: Implications for outbreak control. Clin Infect Dis 2009; 49:584-7
20. Van Savage J, Decker MD, Edwards KM, Sell SH, Karzon DT. Natural history of pertussis antibody in the infant and effect on vaccine response. J Infect Dis 1990; 161:487-92. (Pubitemid 20107950)
21. Shakib JH, Ralston S, Raissy HH, Stoddard GJ, Edwards KM, Byington CL. Pertussis antibodies in postpartum women and their newborns. J Perinatol 2010; 30:93-7
22. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis 2004; 190:335-40. (Pubitemid 38951975)
23. Lichty JA, Slavin B, Bradford WL. An attempt to increase resistance to pertussis in newborn infants by immunizing their mothers during pregnancy. J Clin Invest 1938; 17:613-21
24. Kendrick P, Eldering G, Thompson M. Reenforcing or booster injection of pertussis vaccine in previously immunized children of kindergarten age. Am J Dis Child 1946; 72:382-8
25. Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics 1995; 96:580-4
26. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (.Tdap) in pregnant women-Advisory Committee on Immunization Practices (.ACIP), 2012. MMWR 2013; 62:131-5
27. Belloni C, De Silvestri A, Tinelli C, et al. Immunogenicity of a threecomponent acellular pertussis vaccine administered at birth. Pediatrics 2003; 111:1042-5. (Pubitemid 36542619)
28. Halasa NB, O'Shea A, Shi JR, LaFleur BJ, Edwards KM. Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine. J Pediatr 2008; 153:327-32
29. Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008; 152:655-60
30. Wood N, McIntyre P, Marshall H, Roberton D. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010; 29:209-15
31. White OJ, Rowe J, Richmond P, et al. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 2010; 28:2648-52
32. de Greeff SC, de Melker HE, van Gageldonk PG, et al. Seroprevalence of pertussis in The Netherlands: Evidence for increased circulation of Bordetella pertussis. PLoS One 2010; 5:e14183
33. De Melker HE, Versteegh FG, Schellekens JF, Teunis PF, KretzschmarM. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect 2006; 53:106-13. (Pubitemid 44028673)
34. Hendrikx LH, Berbers GA, Veenhoven RH, Sanders EA, Buisman AM. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: Effect of vaccine antigen content. Vaccine 2009; 27:6530-6
35. Hendrikx LH, de Rond LG, Oztürk K, et al. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Vaccine 2011; 29:5725-30
36. Hendrikx LH, Oztürk K, de Rond LG, et al. Identifying long-Term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins. Vaccine 2011; 29:1431-7
37. Schure RM, Hendrikx LH, de Rond LG, et al. Differential T- and B-Cell Responses to Pertussis in Acellular Vaccine-Primed versus Whole-Cell Vaccine-Primed Children 2 Years after Preschool Acellular Booster Vaccination. Clin Vaccine Immunol. 2013; 20:1388-95.38
38. Schure RM, de Rond L, Ozturk K, et al. Pertussis circulation has increased T-cell immunity during childhood more than a second acellular booster vaccination in Dutch children 9 years of age. PLoS One 2012; 7:e41928